Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rituximab in the Treatment of Chronic Lymphocytic Leukemia, "CLL NIS"

NCT01178086 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01178086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01178086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rituximab in the Treatment of Chronic Lymphocytic Leukemia, "CLL NIS"
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
February 22, 2010
Completion date
June 30, 2015
Enrollment
681 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphocytic leukemia, chronic